Challenges and Future Direction
Today, the role of the cerebral vasculature in the ageing brain and in the pathogenesis of chronic neurodegenerative disorders and stroke has been recognised. Strategies to circumvent vascular barriers of the CNS to deliver various recombinant proteins, enzymes, and neuropharmaceuticals to selectively target the neuronal populations in affected brain areas has become an imperative of the current neuropharmaceutical industry and an unavoidable component of the everyday lives of general practitioners and clinical neuroscientists.
KeywordsGene Therapy Subarachnoid Haemorrhage Transient Gene Expression Cerebral Blood Vessel Herpes Simplex Virus
Unable to display preview. Download preview PDF.